A Sequential Bioequivalence Design with a Potential Ethical Advantage
Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 4
Abstract
The online version of this article (doi:10.1208/s12248-014-9622-7) contains supplementary material, which is available to authorized users.
Authors and Affiliations
Anders Fuglsang
Keywords
Related Articles
- EP ID EP681707
- DOI 10.1208/s12248-014-9622-7
- Views 102
- Downloads 0
A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity
The online version of this article (doi:10.1208/s12248-016-9871-8) contains supplementary material, which is available to authorized users.
Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats
Literature reports have suggested that hemodynamic response toward organic nitrates may be reduced in obese patients, but this effect has not been studied. We compared the mean arterial pressure (MAP) responses toward si...
Spray-Dried Microparticles Containing Polymeric Micelles Encapsulating Hematoporphyrin
The purpose of this study was to examine the properties of a new pulmonary delivery platform of microparticles containing micelles in which a therapeutic photosensitizing drug, hematoporphyrin (Hp), was encapsulated. Dif...
Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers
Regulators of G protein signaling (RGS) proteins modulate G protein-coupled receptor (GPCR) signaling networks by terminating signals produced by active Gα subunits. RGS17, a member of the RZ subfamily of RGS pro...
Gene-Directed Enzyme Prodrug Therapy
As one targeting strategy of prodrug delivery, gene-directed enzyme prodrug therapy (GDEPT) promises to realize the targeting through its three key features in cancer therapy—cell-specific gene delivery and expre...